Toward a nanomedicine for brain cancer

September 9, 2009
Brain cancer cells like those in this tumor could someday become the target of nanoparticles that in lab experiments seek out and destroy brain cancer cells without harming healthy cells. Credit: Wikimedia Commons

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. The study is scheduled for the Sept. 9 issue of ACS' Nano Letters.

Elena Rozhkova and colleagues note the pressing need for new ways to treat the disease, glioblastoma multiforme (GBM), which often causes death within months of diagnosis. Recent studies show that titanium dioxide nanoparticles, a type of light-sensitive material widely used in sunscreens, cosmetics, and even wastewater treatment, can destroy some cancer cells when the chemical is exposed to ultraviolet light. However, scientists have had difficulty getting nanoparticles, each about 1/50,000th the width of a human hair, to target and enter cancer cells while avoiding healthy cells.

The scientists' solution involves chemically linked nanoparticles to an antibody that recognizes and attaches to GMB cells. When they exposed cultured human GMB cells to these so-called "nanobio hybrids," the nanoparticles killed up to 80 percent of the brain cancer cells after 5 minutes of exposure to focused white light. The results suggest that these nanoparticles could become a promising part of brain cancer therapy, when used during surgery, the researchers say.

More information: "A High-Performance Nanobio Photocatalyst for Targeted Therapy", .

Source: American Chemical Society (news : web)

Explore further: Scientists develop targeted cancer treatment using nanomaterials

Related Stories

Nanoparticles Yield Safer Light-Activated Cancer Therapy

September 27, 2007

Photodynamic therapy, in which light activates a chemical known as a photosensitizer, triggering the production of cell-killing reactive oxygen, has proven itself as an effective therapy for a limited number of cancers.

Nanoparticles and Lasers Create Cancer-Killing Microbubbles

June 19, 2006

One promising use of gold nanoparticles is to use them to convert laser energy into heat that can kill malignant cells. Now, in a promising twist on this approach to anticancer therapy, an international team of investigators ...

Gold Nanoparticles May Simplify Cancer Detection

May 9, 2005

Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, suggests research at the Georgia Institute of Technology and the University of California at San Francisco (UCSF). ...

Nanoscale 'Egg' Kills Tumor Cells with Platinum

January 22, 2007

Researchers at the Hong Kong University of Science and Technology have developed a nanoscale “egg” that could safely deliver platinum, a known anticancer agent, to tumor cells. Tests with this nanoscale egg, which has ...

Recommended for you

Clothing fabric keeps you cool in the heat

November 16, 2017

(Phys.org)—Researchers have designed a thermal regulation textile that has a 55% greater cooling effect than cotton, which translates to cooler skin temperatures when wearing clothes made of the new fabric. The material ...

Semiconductors with an aligned interface

November 13, 2017

The electronic characteristics of an interface between two wide bandgap semiconductors are determined by researchers at KAUST: an insight that will help improve the efficiency of light-emitting and high-power electronic devices.

Zipping DNA

November 13, 2017

ETH researchers have developed a method that allows large amounts of genetic information to be compressed and then decompressed again in cells. This could aid in the development of new therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.